Company Valuation: American Oncology Network, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024
Market Cap 1 - - 56.35 137.1
Change - - - 143.33%
Enterprise Value (EV) - - 125.3 215.2
Change - - - 71.77%
P/E - - -4.32x -5.7x
PBR - - -0.35x -3.31x
PEG - - - 0.2x
Capitalization / Revenue - - 0.04x 0.08x
EV / Revenue - - 0x 0x
EV / EBITDA - - -0x -0x
EV / EBIT - - -0x -0x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 - - -1.365 -0.8874
Distribution rate - - - -
Net sales 1 943.7 1,150 1,279 1,759
EBITDA 1 6.99 12.28 -4.668 -5.575
EBIT 1 0.911 5.566 -13.12 -16.09
Net income 1 -0.105 2.589 -5.542 -3.973
Net Debt 36.34 91.97 68.94 78.1
Reference price 2 9.750 10.045 5.900 5.060
Nbr of stocks (in thousands) - - 9,550 27,096
Announcement Date 1/6/23 4/28/23 3/28/24 3/27/25
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 337M
14.32x0.42x8.87x2.74% 124B
13.83x1.76x8.81x0.76% 88.59B
13.5x1.48x8.95x2.64% 28.95B
23.56x2.62x13.28x1.38% 26.42B
31.54x5.73x23.8x2.21% 21.46B
8x1.43x6.51x-.--% 21.22B
17.23x1.58x8x4.6% 15.97B
13.3x0.98x5.5x3.7% 11.89B
12.46x1.58x7.67x0.92% 11.58B
Average 16.41x 1.95x 10.15x 2.1% 35.07B
Weighted average by Cap. 15.53x 1.51x 9.77x 1.99%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. AONC Stock
  4. Valuation American Oncology Network, Inc.